Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Breast cancer treatment: perspectives on the oncolytic virus

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Jul 13, 2024 4:25pm

67 Views

Post# 36131729

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Breast cancer treatment: perspectives on the oncolytic virus

It's a bit disingenuous to cherry pick information and I can't keep saying this if you're not reading it.... I think he did plenty of good things in office, that's not in question.

You didn't address the list of accusations you said I couldn't produce.

He did an interview where he said he wouldn't release the Epshtein files, go look that up. I suspect there's a whole bunch of folks in government and the media in those documents so it's MAD if anyone singles anyone else out. "When interests converge there is no need for conspiracy theories".

<< Previous

Bullboard Posts

Next >>

The top 10 artificial intelligence penny stocks